HSPB8 and Alzheimer disease: The increase in Hsp22 mRNA expression in aging and AD may be a regulatory mechanism to address deficiencies in proteostasis and the accumulation of misfolded proteins, but we do not see an obvious upregulation of Hsp22 protein levels in brain tissue from AD patients or a mouse model of tauopathy.